Basic Information
| LncRNA/CircRNA Name | FAS-AS1 |
| Synonyms | NA |
| Region | GRCh38_1:29554-31109 |
| Ensemble | |
| Refseq | NR_028371 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, Luciferase Reporter Assay etc |
| Sample | NSCLC tissues and normal tissues ,cell line (BEAS-2B,NCL-H1299, NCL-H460, A549) |
| Expression Pattern | down-regulated |
| Function Description | FAS-AS1 Was Down-Regulated in NSCLC Cells and Inhibited Cell Proliferation,FAS-AS1 overexpression restored the promotion of miR-19a-5p overexpression on proliferation, migration, and invasion of NSCLC cells. |
| Pubmed ID | 32329854 |
| Year | 2020 |
| Title | LncRNA FAS-AS1 inhibits the progression of non-small cell lung cancer through regulating miR-19a-5p. |
External Links
| Links for FAS-AS1 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |